Intravesically administered BCG alternating with IFN‐α vs intravesically administered BCG alone
Disease‐specific mortality ‐ not reported · patients with non‐muscle invasive bladder cancer
Intravesically administered BCG alternating with IFN‐α showed no clear difference in disease‐specific mortality compared with intravesically administered BCG alone (low certainty).
1 finding from 1 review
- Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for treating… 2017 · Cochrane Headline outcomes onlyHR 2.74 [0.73, 10.28]1 study · 205 participantsLow